Flow cytometry and immunofluorescence assays revealed reduced expression of CRC-SC markers, such as CD44, EpCAM, and CD133, in tumor mass samples explanted from EM127-treated mice (Supplementary Fig. 9a, b). This evidence concerns the gene PROM1 and neoplasm.